HBV Discovery Services
A Platform Supporting HBV Drug Discovery
A broad assay platform for the discovery of agents for the treatment of chronic HBV infection.
Services for assay establishment and validation, compound screening and profiling, and support of preclinical studies and clinical trials.
- Drug screening using HBV producing cell lines
- HBV infectious assays
- Reporter assays
- Core protein expression
- Compound profiling
- Clinical virology
- Animal models
- Immunological assays supporting animal models
HBV Drug Discovery
Resource Topics
- Analytical Services
- Autoimmune and Inflammatory Diseases
- Biomarker
- Biophysic
- Cancer Research
- Cardiovascular & Metabolic Diseases
- Central Nervous System & Pain
- Chemistry
- CRISPR
- Discovery Chemistry
- Drug Discovery
- Gene Editing
- Hit Finding
- Hit Finding and Screening Services
- in vitro biology
- in vivo Pharmacology
- Infectious Diseases
- Liver Diseases
- Oncology & Immuno-oncology
- Protein Services
- Respiratory Diseases
- Screening
- Structural Biology
- Target Validation
- Technologies
- Therapeutic Modalities